Carteolol Hydrochloride (Sandoz Inc.)


Welcome to the PulseAid listing for the Carteolol Hydrochloride drug offered from Sandoz Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc.
NON-PROPRIETARY NAME: Carteolol Hydrochloride
SUBSTANCE NAME: CARTEOLOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2000-01-05
END MARKETING DATE: 0000-00-00


Carteolol Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCarteolol Hydrochloride from Sandoz Inc.
LABELER NAME: Sandoz Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2000-01-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61314-238_f507500a-ed39-301f-8e85-ae898a81a313
PRODUCT NDC: 61314-238
APPLICATION NUMBER: ANDA075476

Other CARTEOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bausch & Lomb IncorporatedCARTEOLOL HYDROCHLORIDE
Medsource PharmaceuticalsCARTEOLOL HYDROCHLORIDE
Sandoz Inc.Carteolol Hydrochloride